Cardiac rehabilitation during COVID-19 pandemic – new challenges, new opportunities Review article
Main Article Content
Abstract
The role of comprehensive cardiac rehabilitation (CCR) is well established in the secondary prevention of cardiovascular diseases such as coronary artery disease and heart failure. Many clinical trials demonstrated effectiveness of CCR in improving exercise capacity, quality of life, and in reducing cardiovascular mortality and morbidity. However, even before the era of the COVID-19 pandemic comprehensive cardiac rehabilitation program’s implementation, especially the second phase, had many barriers. One of the main reasons for not attending in second phase of CCR was lack of transportation from patient’s home to rehabilitation centers.
Additionally, in recent months COVID-19 pandemic has led to closure of many cardiac rehabilitation centres resulting in many eligible patients unable to participate in the optimisation of secondary prevention. During the coronavirus disease-2019 pandemic, hybrid telerehabilitation has become the leading solution in the cardiac rehabilitation programs. The present paper contains key information about structures, effectives and safety of hybrid telerehabilitation during the COVID-19 era.
Article Details
Copyright © by Medical Education. All rights reserved.
References
2. Benzer W, Rauch B, Schmid JP et al; EuroCaReD study group. Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry. Int J Cardiol. 2017; 228: 58-67.
3. Rauch B, Davos CH, Doherty P et al; Cardiac Rehabilitation Section, European Association of Preventive Cardiology (EAPC), in cooperation with the Institute of Medical Biometry and Informatics (IMBI), Department of Medical Biometry, University of Heidelberg, Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Heinrich-Heine University, Dusseldorf, Germany. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies – The Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol. 2016; 23(18): 1914-39.
4. Taylor RS, Sagar VA, Davies EJ et al. Exercise-based rehabilitation for heart failure. Cochrane Database Syst Rev. 2014; 2014: 4.
5. Knuuti J, Wijns W, Saraste A et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020; 41(3): 407-77.
6. Ibanez B, James S, Agewall S et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119-77.
7. Collet JP, Thiele H, Barbato E et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021; 42(14): 1289-367.
8. Ponikowski P, Voors AA, Anker SD et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129-200.
9. Gałaszek M. Aktualny stan rehabilitacji kardiologicznej w Polsce. Sekcja Rehabilitacji Kardiologicznej i Fizjoterapii Wysiłku, Polskie Towarzystwo Kardiologiczne, Ustroń 2015.
10. Jankowski P, Gąsior M, Gierlotka M et al. Opieka koordynowana po zawale serca. Stanowisko Polskiego Towarzystwa Kardiologicznego oraz Agencji Oceny Technologii Medycznych i Taryfikacji. Kardiol Pol. 2016; 74(8): 800-11.
11. Piotrowicz R, Jegier A, Szalewska D et al. Rekomendacje w zakresie realizacji kompleksowej rehabilitacji kardiologicznej: stanowisko ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego. Wydawnictwo Asteria Med, Warszawa 2017.
12. Piotrowicz R, Krzesiński P, Balsam P et al. Rozwiązania telemedyczne w kardiologii – opinia ekspertów Komisji Informatyki i Telemedycyny Polskiego Towarzystwa Kardiologicznego, Sekcji Elektrokardiologii Nieinwazyjnej i Telemedycyny Polskiego Towarzystwa Kardiologicznego oraz Komitetu Nauk Klinicznych Polskiej Akademii Nauk. Kardiol Pol. 2018; 76(3): 698-707.
13. Scherrenberg M, Wilhelm M, Hansen D et al. The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology [published online ahead of print]. Eur J Prev Cardiol. 2020; 2047487320939671.
14. Lyngå P, Persson H, Hägg-Martinell A et al. Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial. Eur J Heart Fail. 2012; 14(4): 438-44. http://doi.org/10.1093/eurjhf/hfs023.
15. Piotrowicz E, Baranowski R, Bilinska M et al. A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. Eur J Heart Fail. 2010; 12(2): 164-71.
16. Scheinowitz M, Harpaz D. Safety of cardiac rehabilitation in a medically supervised, community-based program. Cardiology. 2005; 103(3): 113-7.
17. Batalik L, Filakova K, Batalikova K et al. Remotely monitored telerehabilitation for cardiac patients: A review of the current situation. World J Clin Cases. 2020; 8(10): 1818-31.
18. Niewada M, Tabor B, Piotrowicz E et al. Cost-effectiveness of telerehabilitation in patients with heart failure in Poland: an analysis based on the results of Telerehabilitation in the Heart Failure Patients (TELEREH-HF) randomized clinical trial. Kardiol Pol. 2021; 79(5): 510-6.
19. Scherrenberg M, Falter M, Dendale P. Cost-effectiveness of different models of cardiac telerehabilitation. Kardiol Pol. 2021; 79(5): 489-90.